Drug intelligence / Profile preview

acetylsalicylic acid + sodium bicarbonate + citric acid

Development stage
Unknown
Lead developer
Miles
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

This drug is a fixed-dose combination of three active ingredients: acetylsalicylic acid (aspirin), sodium bicarbonate, and citric acid. Aspirin is a non-steroidal anti-inflammatory drug (NSAID) that acts as an analgesic and antipyretic by irreversibly inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins involved in pain, inflammation, and fever. It also inhibits platelet aggregation by blocking thromboxane A2 production. Sodium bicarbonate is an antacid that neutralizes excess gastric acidity through a chemical reaction with stomach hydrochloric acid. Citric acid reacts with sodium bicarbonate to produce effervescence when dissolved in water, aiding palatability and further buffering stomach acidity. The combination is primarily used for the relief of minor aches and pains accompanied by heartburn or indigestion but may also be used to reduce the risk of blood clots under medical supervision[1][3][6][7]. Developed originally by Dr. Miles Medicine Company in 1931, it has been owned by Bayer since 1978[6].

Brand names
Alka-SeltzerAlka-Seltzer OriginalAlka-Seltzer Extra StrengthPain Relief EffervescentAlcortin A
Other names
aspirin, sodium bicarbonate, and citric acidaspirin-citric acid-sodium bicarbonate
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on acetylsalicylic acid + sodium bicarbonate + citric acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetylsalicylic acid + sodium bicarbonate + citric acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call